FRATAXAV Trademark

Trademark Overview


On Thursday, July 20, 2023, a trademark application was filed for FRATAXAV with the United States Patent and Trademark Office. The USPTO has given the FRATAXAV trademark a serial number of 79382527. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, April 29, 2024. This trademark is owned by BIOINTAXIS, S.L.. The FRATAXAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products
frataxav

General Information


Serial Number79382527
Word MarkFRATAXAV
Filing DateThursday, July 20, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOINTAXIS, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 10, 2023APPLICATION FILING RECEIPT MAILED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Tuesday, April 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, April 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 29, 2024REFUSAL PROCESSED BY MPU
Wednesday, May 22, 2024REFUSAL PROCESSED BY IB

Related Keywords


frataxav products pharmaceutical